Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | PDE2A | O00408 | 4/20 | 0.44 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 4/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146337 | 0.84 | SLC6A4 (0.43) | DAOPDE2AIDO1HTR2ASLC6A4 | |
| SCHEMBL3211500 | 0.82 | DAO (0.49) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL92913 | 0.80 | PDE2A (0.49) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL15684775 | 0.80 | DAO (0.48) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL2669965 | 0.80 | DAO (0.51) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL3208015 | 0.80 | PDE2A (0.49) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL963581 | 0.80 | DAO (0.48) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL30523915 | 0.80 | PDE2A (0.49) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| Hydrochloric Acid SCHEMBL968626 | 0.78 | DAO (0.47) | DAOPDE2AMRGPRX4IDO1HTR2A | |
| SCHEMBL147650 | 0.78 | DAO (0.46) | DAOIDO1SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114729006-A | Cyclic peptide compounds having Kras inhibitory activity | 中外制药株式会社 | 2022-07-08 | — | — | CN | disclosed |
| US-8426631-B2 | Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same | BASF SE (DE) | 2013-04-23 | — | — | US | disclosed |
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | BASF SE (DE) | 2010-12-02 | — | — | US | disclosed |
| EP-0120352-B1 | DERIVATIVES OF N-ACYLANTHRANILIC ACIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COMBATING WEEDS | BASF Aktiengesellschaft (DE) | 1990-06-13 | — | — | EP | disclosed |
| US-4622397-A | HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1986-11-11 | — | — | US | disclosed |
| EP-0078462-B1 | 1,2,4,6-THIATRIAZINE-1,1 DIOXIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTI-GROWTH AGENTS FOR UNWANTED PLANTS | BASF Aktiengesellschaft (DE) | 1986-01-15 | — | — | EP | disclosed |
| EP-0168352-A1 | Method for the preparation of amino-triazinone derivatives | CIBA-GEIGY AG (CH) | 1986-01-15 | — | — | EP | disclosed |
| EP-0120352-A1 | Derivatives of N-acylanthranilic acids, process for their preparation and their use in combating weeds | BASF Aktiengesellschaft (DE) | 1984-10-03 | — | — | EP | disclosed |
| US-4472191-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1984-09-18 | — | — | US | disclosed |
| EP-0078462-A1 | 1,2,4,6-Thiatriazine-1,1 dioxides, process for their preparation and their use as anti-growth agents for unwanted plants | BASF Aktiengesellschaft (DE) | 1983-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100304966-A1 | Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same | CYP51A1, ERG28, CAT | DAO 257/4885PDE2A 223/4885MRGPRX4 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.